Linkage to Care - Part I

This first phase of a two-phase study involves three components:

1. Review of existing linkage-to-care protocols and sources of referrals for care; 2. Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Preference will be given to personnel with direct experience in linkage to care); and 3. Structured observations of referral sessions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Children's National Medical Center, Washington D.C., District of Columbia, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Component 1: Documents identified by clinical site personnel as pertaining to post-test counseling, linkage to care, or standard operating procedures addressing post-test counseling and linkage to care.
Component 2: Persons employed by one of the AMTUs or an identified linkage-to-care partner and work as clinical staff or a case-manager or is a person familiar to linkage to care; or persons involved in posttest counseling and linkage-to-care processes. Clinical staff and case managers are chosen based on direct experience in the assistance of HIV seropositive youth obtaining medical care. This definition includes, but is not limited to, physicians, nurses, psychologists, social workers, and case managers (who may have diverse professional backgrounds).
Component 3: All AMTU sites will be included.

Exclusion criteria

Component 1: No a priori exclusions.
Component 2: No a priori exclusions.
Component 3: No a priori exclusions.

Treatment and study plan

Primary outcomes

Describe and evaluate community screening standards and practices.

Time frame: 1 year
Describe and evaluate the relationships of screening venues with care-providing venues.

Time frame: 1 year
Describe and evaluate referral and intake protocols.

Time frame: 1 year
Describe and evaluate care adherence support (including support from both clinical and non-clinical sources).

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

National Institute of Mental Health (NIMH)
National Institute on Drug Abuse (NIDA)

Registry information

Official study title

HIV-Related Care Engagement: Linkage to Care and Care-Seeking for HIV-Infected Adolescents, Phase I

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: Jun 23, 2008
Registry last updated: Feb 28, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed